Finance

Lists
APOLLOHOSP:NSE
Apollo Hospitals Enterprise Ltd
7 889,50 INR
+0,84%
(+65,50) 1D
15-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APOLLOHOSP...
Open
7 812,00 INR
High
7 966,50 INR
Low
7 767,50 INR
Mkt. cap
1,14 трлн
Avg. vol.
539,82 миң
Volume
439,96 миң
Dividend
0,25%
Quarterly dividend
5,00 INR
Ex-dividend date
2026-ж., 16-фев.
P/E ratio
54,33
52-wk high
9 070,50 INR
52-wk low
6 696,50 INR
EPS
145,21 INR
Shares outstanding
139,13 млн
No. of employees
44 миң
Open
7 812,00 INR
High
7 966,50 INR
Low
7 767,50 INR
Mkt. cap
1,14 трлн
Avg. vol.
539,82 миң
Volume
439,96 миң
Dividend
0,25%
Quarterly dividend
5,00 INR
Ex-dividend date
2026-ж., 16-фев.
P/E ratio
54,33
52-wk high
9 070,50 INR
52-wk low
6 696,50 INR
EPS
145,21 INR
Shares outstanding
139,13 млн
No. of employees
44 миң
News stories
From web sources and news partners
Profile
Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the second largest for-profit private hospital network in India after Manipal Hospitals, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries. The company was founded by Prathap C. Reddy in 1983 as the first corporate healthcare provider in India. Several of Apollo's hospitals have been among the first in India to receive international healthcare accreditation by the America-based Joint Commission International as well as NABH accreditation. Apollo Hospitals and its subsidiaries have faced multiple allegations of overcharging, forceful transplants, and corruption. Wikipedia
About Apollo Hospitals Enterprise Ltd
CEO-
Employees44 миң
Founded1983-ж., 18-сен.
Headquarters-
SectorHealth care provider
Last report
2026-ж., 13-авг.
Fiscal period
Q1 2027
40,37 INR / 39,58 INR
+1,99%beat
Revenue / Est. (INR)
70,44 млд / 68,91 млд
+2,21%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
63,04 млд
64,77 млд
66,06 млд
70,44 млд
Cost of goods sold
40,10 млд
41,31 млд
45,90 млд
43,93 млд
Cost of revenue
40,10 млд
41,31 млд
45,90 млд
43,93 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
6,12 млд
-
Operating expense
15,70 млд
16,00 млд
12,18 млд
17,94 млд
Total operating expenses
55,80 млд
57,31 млд
58,09 млд
61,86 млд
Operating income
7,23 млд
7,46 млд
7,97 млд
8,57 млд
Other non operating income
547,00 млн
528,00 млн
-2,14 млд
488,00 млн
EBT including unusual items
6,75 млд
6,82 млд
7,22 млд
7,99 млд
EBT excluding unusual items
6,75 млд
7,01 млд
6,43 млд
7,99 млд
Income tax expense
1,81 млд
1,66 млд
1,70 млд
1,88 млд
Effective tax rate
26,78%
24,30%
23,58%
23,59%
Other operating expenses
13,52 млд
13,81 млд
3,82 млд
15,58 млд
Net income
4,77 млд
5,02 млд
5,29 млд
5,81 млд
Net profit margin
7,57%
7,75%
8,01%
8,24%
Earnings per share
33,19
35,95
36,76
40,37
Interest and investment income
-
-
767,00 млн
-
Interest expense
-1,10 млд
-1,13 млд
-256,00 млн
-1,20 млд
Net interest expenses
-1,10 млд
-1,13 млд
511,00 млн
-1,20 млд
Depreciation and amortization charges
2,18 млд
2,19 млд
2,24 млд
2,35 млд
EBITDA
9,40 млд
8,77 млд
9,37 млд
9,97 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору